ArticleFrontiers in oncology2021

SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer.

Juanjuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.